References
- Birgegard G., Wide L., Siminsson B. Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs, suggest mechanism other than anaemia for stimulation. British Journal of Haematology 1989; 12: 462–466
- Bull J. M., Lees D., Schuette W. H., Smith R., Glatstein E., Devita V. T. Immunological and physiological responses to whole-body hyperthermia. NCI Monograms 1982; 61: 177–181
- Cazzola M., Messinger D., Battistel V., Bron D., Cimino R., Enller-Ziegler L., Essers U., Greil R., Grossi A., Jaeger G., Lemevel A., Najman A., Silingardi V., Spriano M., Van Hoof A., Ehmer B. Recombinant human erythropoietin in the anemia associated with multiple myeloma of non-hodgkin's lymphoma: dose finding and identification of predictors of response. Blood 1995; 86: 4446–453
- D'Oleire F., Schmitt C. L., Robins H. I., Cohen J. D., Sprigg D. J. Cytokine induction in humans by 41.8°C whole body hyperthermia. Journal of the National Cancer Institute 1993; 85: 833–834
- Erslev A. J. Erythropoietin liters in health and disease. Sem Hematol 1991; 28: 2–8
- Grace R. J., Kedall R. G., Chapman C., Hartley A. E., Barnard D. L., Norfolk D. R. Changes in serum erythropoietin level during allogenic bone marrow transplantation. European Journal of Haematology 1991; 47: 81–85
- Ludwig H., Fritz E., Kotzmann H., Hoekker P., Gisslinger H., Barnas U. Erythropoietin treatment of anaemia associated with multiple myeloma. New England Journal of Medicine 1990; 322: 1693–1699
- Ludwig H. M., Fritz E., Leitgeb C., Perchersdorfer M., Samonigg H., Schuster J. Prediction of response to erythropoietin treatment in chronic anemia of cancer. Blood 1994; 84: 1056–1063
- Miller C. B., Jones R. J., Piantadosi S., Abeloff M. D., Spivak J. L. Decreased erythropoietin response in patients with the anemia of cancer. New England Journal of Medicine 1990; 322: 1689–1692
- Nielsen O. J. Determination of human erythropoietin by radioimmunoassay. Method and clinical data. Clinica Chimica Acta 1988; 176: 303–314
- Piroso E., Erslev A. J., Caro J. Inappropriate increase in erythropoietin tilers during chemotherapy. Am J Hematol 1989; 32: 248–254
- Robins H. I., Kalin N., Shelton S. E., Shecterle L., Marshal J., Barksdale C. N. Neuroendocrine changes in patients undergoing whole body hyperthermia. International Journal of Hyperthermia 1987; 3: 99–105
- Robins H. I., Kutz M., Wiedemann G. J., Katschinski D. M., Paul D., Grosen E., Tiggelaar C. L., Spriggs D., Gillis W., D'Oleire F. Cytokine induction by 41.8°C whole body hyperthermia. Cancer letters 1995; 97: 195–201
- Robins H. I., Rushing D., Kutz M., Tutsch K., Tiggelaar C. L., Paul D., Spriggs D., Kraemer C., Gillis W., Feierabend C., Arzoomanian R. Z., Longo W., Alberti D., D'Oleire F., Qu R. P., Wilding G., Stewart J. A. Phase I clinical trial of melphalan and 41.8°C whole-body hyperthermia in cancer patients. Journal of Clinical Oncology 1997; 15: 158–164
- Robins H. I., Woods J. P., Schmitt C. L., Cohen J. D. A new technological approach to radiant heat whole body hyperthermia. Cancer letters 1994; 79: 137–145
- Schapira L., Antin J. A., Ransil J., Antman K. H., Eder J. P., McGarigle C. J., Goldberg M. A. Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 1990; 76: 2354–2359